Medicamen Organics Limited — QIP/Rights/Pref., 08-01-2025: Preferential issue

Medicamen Organics has announced a board meeting outcome detailing a preferential issue aimed at raising funds of up to ₹3 crore through the issuance of 4,65,910 convertible warrants at ₹64.39 per warrant. These warrants entitle holders to convert them into fully paid-up equity shares at a premium of ₹54.39 each within 18 months from allotment. The approval for this issuance will be sought from shareholders via a postal ballot. Post-allotment, the promoter's stake will increase from 59.69% to 61.24% based on fully diluted shares.